Author: Dr Mark Flear
-
Britain’s Pharmaceutical Industry and No Deal
The spectre of ‘no deal’ has always loomed large over negotiations for a new relationship between the UK and EU. Every economic sector fears unprecedented disruption, but in the health sector, it is exacerbated by the equally unprecedented disruption associated with Covid-19 says Dr Mark Flear and Professor Tamara Hervey from the University of Sheffield.
-
Coronavirus shows how UK must act quickly before being shut out of Europe’s health protection systems
The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Professor Anniek de Ruijter of the University of Amsterdam, Professor Martin McKee of the London School of Hygiene & Tropical Medicine, and QUB’s Dr Mark Flear.